258 related articles for article (PubMed ID: 20526551)
1. Primary cutaneous intravascular large B-cell lymphoma treated with combination chemotherapy and complicated by rituximab-induced interstitial lung disease.
Park GH; Kim CH; Chung WK; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
Acta Derm Venereol; 2010 May; 90(3):296-8. PubMed ID: 20526551
[No Abstract] [Full Text] [Related]
2. Intravascular large B-cell lymphoma of the skin: typical clinical manifestations and a favourable response to rituximab-containing therapy.
Feldmann R; Schierl M; Sittenthaler M; Jahn R; Wogritsch C; Cerroni L; Steiner A; Breier F
Dermatology; 2009; 219(4):344-6. PubMed ID: 19590171
[TBL] [Abstract][Full Text] [Related]
3. Intravascular large B-cell lymphoma: remission after rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy.
Horváth B; Demeter J; Eros N; Hársing J; Csomor J; Matolcsy A; Bottlik G; Gyori G; Marschalkó M; Kárpáti S
J Am Acad Dermatol; 2009 Nov; 61(5):885-8. PubMed ID: 19632742
[TBL] [Abstract][Full Text] [Related]
4. What is your diagnosis? Cutaneous B-cell lymphoma.
Carlson SW; Aneja S; Honda K; Cooper KD
Cutis; 2014 Nov; 94(5):217, quiz 249-51. PubMed ID: 25474456
[No Abstract] [Full Text] [Related]
5. [A case of pulmonary intravascular lymphoma treated with CHOP chemotherapy plus rituximab].
Ohkubo H; Yoshida T; Ohta K; Takaku T; Katagiri T; Paku J; Kasuga I; Minemura K; Gotoh A; Serizawa H; Mukai K; Ohyashiki K
Gan To Kagaku Ryoho; 2005 Apr; 32(4):553-6. PubMed ID: 15853227
[TBL] [Abstract][Full Text] [Related]
6. [Intravascular large B-cell lymphoma with massive pulmonary lesions].
Higashiyama A; Hashino S; Onozawa M; Takahata M; Okada K; Kahata K; Taniguchi N; Nasuhara Y; Kubota K; Fujimoto N; Matsuno Y; Nishimura M; Asaka M
Rinsho Ketsueki; 2010 May; 51(5):353-6. PubMed ID: 20534958
[TBL] [Abstract][Full Text] [Related]
7. [Interest of an intensive chemotherapy for intravascular large B cell lymphoma].
Baldolli A; Chuffart M; Geffray L; Verneuil L; Reman O
Bull Cancer; 2013 Apr; 100(4):317-21. PubMed ID: 23587663
[TBL] [Abstract][Full Text] [Related]
8. Rituximab CHOP for successful management of diffuse large B-cell lymphoma of the ovary.
Ahbeddou N; Fetohi M; Khanoussi BE; Errihani H
Arch Gynecol Obstet; 2011 May; 283(5):1173-4. PubMed ID: 20957380
[No Abstract] [Full Text] [Related]
9. Two Cases of Intravascular Lymphoma Diagnosed by Gastrointestinal Endoscopic Biopsy.
Shimoyama Y; Sugimoto K; Kotake M; Uehara D; Kamide Y; Kuribayashi S; Kawamura O; Kusano M; Handa H; Hirato J; Yamada M
Intern Med; 2015; 54(24):3145-9. PubMed ID: 26666601
[TBL] [Abstract][Full Text] [Related]
10. Persistent panhypogammaglobulinemia after CHOP-rituximab for HIV-related lymphoma.
Miles SA; McGratten M
J Clin Oncol; 2005 Jan; 23(1):247-8. PubMed ID: 15625386
[No Abstract] [Full Text] [Related]
11. Primary cutaneous large B-cell lymphoma, leg type, successfully treated with rituximab plus chemotherapy.
Posada García C; Florez A; Pardavila R; Garcia-Cruz A; Amador L; Alvarez M; Alberte LM; Cruces MJ
Eur J Dermatol; 2009; 19(4):394-5. PubMed ID: 19467966
[No Abstract] [Full Text] [Related]
12. Brief-duration rituximab/chemotherapy followed by maintenance rituximab in patients with diffuse large B-cell lymphoma who are poor candidates for R-CHOP chemotherapy: a phase II trial of the Sarah Cannon Oncology Research Consortium.
Hainsworth JD; Flinn IW; Spigel DR; Clark BL; Griner PL; Vazquez ER; Doss HH; Shipley D; Franco LA; Burris HA; Greco FA;
Clin Lymphoma Myeloma Leuk; 2010 Feb; 10(1):44-50. PubMed ID: 20223728
[TBL] [Abstract][Full Text] [Related]
13. Addictive response of primary cutaneous diffuse large B cell lymphoma leg type to low-dose ibrutinib.
Pang A; Au-Yeung R; Leung RYY; Kwong YL
Ann Hematol; 2019 Oct; 98(10):2433-2436. PubMed ID: 31446456
[No Abstract] [Full Text] [Related]
14. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
[TBL] [Abstract][Full Text] [Related]
15. Treatment of cutaneous B-cell lymphoma, leg type, with age-adapted combinations of chemotherapies and rituximab.
Grange F; Maubec E; Bagot M; Beylot-Barry M; Joly P; Dalle S; Delaporte E; Dereure O; Bachelez H; Vergier B; Petrella T; D'Incan M
Arch Dermatol; 2009 Mar; 145(3):329-30. PubMed ID: 19289772
[No Abstract] [Full Text] [Related]
16. [Beneficial effects of CHOP therapy in a case of intravascular large B-cell lymphoma diagnosed by skin biopsy].
Munakata S; Hirano S; Yoshiyama Y; Koizumi M; Kobayasi T; Hattori T
Rinsho Shinkeigaku; 2000 May; 40(5):476-9. PubMed ID: 11002731
[TBL] [Abstract][Full Text] [Related]
17. Rituximab in heavily pretreated cutaneous B-cell lymphoma.
Zinzani PL; Stefoni V; Alinari L; Vianelli N; Baccarani M
Leuk Lymphoma; 2003 Sep; 44(9):1637-8. PubMed ID: 14565673
[No Abstract] [Full Text] [Related]
18. [Ictus cerebellopontine as first manifestation of an intravascular diffuse large B cell lymphoma involving at the kidney].
Sagüés M; Paredes V; Altés J; Fernández de Sevilla A
Med Clin (Barc); 2015 Jan; 144(1):48-9. PubMed ID: 24698716
[No Abstract] [Full Text] [Related]
19. Rituximab with chemotherapy improves survival of non-germinal center type untreated diffuse large B-cell lymphoma.
Saito B; Shiozawa E; Usui T; Nakashima H; Maeda T; Hattori N; Shimozuma J; Adachi D; Yamochi-Onizuka T; Takimoto M; Nakamaki T; Ota H; Tomoyasu S
Leukemia; 2007 Dec; 21(12):2563-6. PubMed ID: 17597802
[No Abstract] [Full Text] [Related]
20. Intravascular large B cell lymphoma: widespread but not everywhere.
Ponzoni M; Ferreri AJ
Acta Haematol; 2014; 131(1):16-7. PubMed ID: 24021531
[No Abstract] [Full Text] [Related]
[Next] [New Search]
